Hold-rated reports

932 tickers rated Hold
Ranks this page's recent reports by score.
Dana Incorporated
DAN·Consumer Discretionary
B ★★★Hold
Current$23.11
Target$31.50
Return+36.3%
Oct 31, 2026

Dana offers a potentially undervalued automotive-supplier turnaround supported by margin expansion, deleveraging, and Eaton Mobility synergies, but weak cash conversion and merger execution risks constrain conviction.

Score
71
WEX Inc.
WEX·Technology
B ★★★Hold
Current$184.61
Target$207.00
Return+12.1%
Oct 31, 2026

WEX combines embedded commercial payments, improving margins, and shareholder-friendly buybacks with a modest earnings valuation, but weak organic growth and volatile cash conversion limit the near-term upside case.

Score
73
Brinker International, Inc.
EAT·Consumer Discretionary
B ★★★Hold
Current$212.18
Target$231.20
Return+9.0%
Oct 31, 2026

Brinker International benefits from Chili's sustained traffic growth, improved restaurant margins, and strong cash generation, but its valuation and dependence on continued casual-dining outperformance limit the margin of safety.

Score
71
Lennox International Inc.
LII·Industrials
B ★★★Hold
Current$344.08
Target$414.00
Return+20.3%
Oct 31, 2026

Lennox offers a high-return HVAC franchise with strong commercial growth and a discounted valuation, but residential pricing pressure and persistent cost inflation threaten its earnings recovery.

Score
74
Labcorp Holdings Inc.
LH·Healthcare
B ★★★Hold
Current$361.39
Target$391.20
Return+8.2%
Oct 31, 2026

Labcorp benefits from a durable national diagnostics network, recurring healthcare demand, and growing specialty testing, but premium valuation, reimbursement pressure, and acquisition execution risks constrain prospective returns.

Score
69
Honeywell Aerospace Inc.
HONA·Industrials
B ★★★Hold
Current$154.15
Target$184.80
Return+19.9%
Oct 31, 2026

Honeywell Aerospace's certified aircraft systems, recurring aftermarket demand, and expanding backlog support long-term earnings recovery, but persistent supplier bottlenecks and elevated post-spin-off leverage constrain near-term returns.

Score
69
Carvana Co.
CVNA·Consumer Discretionary
B ★★★Hold
Current$68.29
Target$75.00
Return+9.8%
Oct 31, 2026

Carvana's integrated online vehicle-retail platform can compound earnings through sustained market-share gains and operating scale, but demanding valuation multiples and financing-sensitive margins limit the margin of safety.

Score
70
American Electric Power Company, Inc.
AEP·Utilities
B ★★★Hold
Current$130.21
Target$138.00
Return+6.0%
Oct 31, 2026

American Electric Power offers durable regulated utility earnings and accelerated growth from electricity infrastructure demand, but elevated historical valuation and the funding burden of its $100B capital program constrain near-term upside.

Score
68
Biogen Inc.
BIIB·Healthcare
B ★★★Hold
Current$253.62
Target$264.00
Return+4.1%
Oct 31, 2026

Biogen's expanding neurology and immunology portfolio can restore durable earnings growth, but legacy drug erosion, elevated acquisition debt, and demanding recovery expectations constrain the margin of safety.

Score
69
O'Reilly Automotive, Inc.
ORLY·Consumer Discretionary
B ★★★Hold
Current$88.12
Target$98.80
Return+12.1%
Oct 31, 2026

O'Reilly combines a durable automotive aftermarket distribution moat, exceptional returns on capital, and consistent earnings growth, but its premium valuation and leveraged repurchase strategy limit the margin of safety.

Score
71